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On demand modulation of lipid composition in an in-
dividual bilayer†
John S. H. Danial,a‡ Bríd Cronin,a Chandini Mallik,a and Mark I. Walllace.∗a,b
Changes in local lipid composition are thought to play a key role in regulating many complex
cellular processes. By studying lipid organization in artificial lipid bilayers the physical principles
underlying these process can be studied in detail. However, such in vitro measurements are
often hindered by heterogeneities in the lipid composition of individual bilayers prepared by cur-
rent bulk methods. Here, the lipid composition of an individual Droplet Interface Bilayer is varied
by lipid titration into the bilayer from the oil phase in a microfluidic device. Control of lipid com-
position allows the reversible switching between single- and two-phase regions and sampling of
specific lipid compositions in an individual bilayer. This method enables controlled modulation of
composition-sensitive processes in a single lipid membrane.
Introduction
The intrinsic modulation of lipid composition in cells exerts pro-
found and complicated influences on their organization1–3. Arti-
ficial lipid bilayers have helped us understand how phase separa-
tion occurs in lipid membranes, reducing membrane complexity5
down to a small number of well-defined components whose prop-
erties can be predicted4–6. Giant Unilamellar Vesicles (GUVs) in
particular have been used to study lipid phase separation; map-
ping out phase diagrams7,8 and investigate the dynamics of lipid
domains9–11.10
Despite their usefulness, phase separated GUVs show signifi-
cant variations in their transition temperature and area fraction
within the same preparation9,12,13; similar inhomogeneity has
also been recently reported for small unilamellar vesicles14. GUV
heterogeneity is thought to be due to the inhomogeneous mix-15
ing of lipids in the dry film state15 and the on-going fusion of
additional vesicles to form GUVs of unknown compositions8. In
effect, the irregularities observed across GUVs are inherit to bulk
preparation methods which lack precise and immediate control
over processes culminating to bilayer formation. Controlling the20
humidity during lipid film preparation has been reported to ame-
liorate this problem at the expense of long (24 hr) preparation
times15. Microfluidics have also helped solve these problems, cir-
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cumventing the size heterogeneity introduced by GUV electrofor-
mation16,17. Notably, microfluidics have been recently applied to
create phase-separated GUVs using water-in-oil-in-water double
emulsions18; but these experiments require the fabrication and
control of complex devices capable of supporting controlled mul- 5
tiphase flow. Despite these important advances, precise control
of bilayer composition remain a significant hurdle to more com-
plex uses of GUVs as mimics of the cell, for example in controlling
membrane shape18–20 and budding in response to changes in the
external environment21,22. 10
In addition to these unwanted intrinsic changes in membrane
composition, intentional changes in composition are also possi-
ble: Established methods to induce changes to membrane com-
position rely on the use of reagents that remove specific bilayer
components6,23,24. For example, methyl-β -cyclodextrin can be 15
used to modulate the composition of lipid membranes via choles-
terol depletion. However, these methods do not enable systematic
and precise changes to the composition of lipid bilayers, as the
membrane lipid composition after application of these reagents is
unknown. Lipid transfer from vesicles to both supported lipid bi- 20
layers25,26 and more recently between GUVs8 has also been used
to modify bilayer composition.
Likewise, Supported Lipid Bilayers (SLBs) have been exten-
sively employed for studying the structural organization of phase-
separated mixtures27? . However, in contrast to GUVs9 the sur- 25
face interactions necessary for SLB formation often result in a
reduction in lipid diffusion28, and immobile domains. Even with
polymer cushions, domains are generally immobile29. He we ex-
ploit the lack of strong substrate interactions in supported Droplet
Interface Bilayers (DIBs) to image mobile domains, with lipid dif- 30
fusion coefficients similar to those observed in free-standing bi-
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A B
Fig. 1 (A) Control of bilayer composition is achieved by titrating lipids
into the oil phase. (B) Image of a phase-separation in a DIB composed
of 1:1:1 DPhPC:DPPC:Chol taken using confocal microscopy. 1 mol%
TRITC-DHPE labelled the Ld phase. Scale bar 50 µm.
layers30.
Here, we exploit the DIB formation process to achieve precise
control of the composition of an individual lipid bilayer (Fig.1).
DIBs are formed in a microfluidic chamber at the contact of a
hydrogel-supported lipid monolayer and a second monolayer sur-5
rounding an aqueous droplet, both immersed in a lipid-in-oil
bath31. We originally developed DIBs to provide high-sensitive
single-molecule fluorescence imaging of a lipid bilayer whilst re-
taining control of the membrane potential32–35. Unlike GUVs,
where changes in lipid mixing can occur as the dry lipid film re-10
hydrates, lipids in DIBs are free to mix both before and after bi-
layer formation, remaining in equilibrium with the lipids solubi-
lized in the surrounding oil. We reasoned that by adding soluble
lipid components to the oil phase surrounding individual DIBs,
we might modulate the lipid composition within the bilayer in15
situ, and observe the subsequent changes in lipid phase separa-
tion (Fig. 1A).
Experimental
Materials. DPhPC, bSM and Chol were obtained from Avanti Po-
lar Lipids (Alabaster, AL). DiI-C18 was obtained from Invitrogen20
(UK). TRITC-DHPE was obtained from VWR (Germany). Lipids
purchased were used without further purification, dissolved in
chloroform at 50 mg ml−1 and stored at -20◦C until use. All other
reagents were obtained from Sigma-Aldrich (Missouri, MO).
DIB formation. DIBs were prepared following our previ-25
ously reported protocol36. Briefly, 50 nL droplets of 90 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) were
incubated for 30 minutes in a solution of the required lipids
(8.7 mg mL−1 total lipids in a mixture of hexadecane and 10%
[v/v] Silicone Oil AR 20) to form a lipid monolayer at the oil-30
water interface. Meanwhile, 140 µL of 0.75% [w/v] low-melt
agarose was spin-coated (Laurell Technologies, US) on a plasma-
cleaned coverslip at 4000 rpm for 30 s. The agarose-coated cover
slip was sealed with a micro-fabricated poly(methyl methacry-
late) (PMMA) microfluidic device (details reported previously36).35
Agarose was used to seal the device onto the coated coverslip.
The device was filled with the specified lipid solution. After
20 minutes droplets were transferred to the device and bilayers
formed upon droplet contact with the agarose substrate. Finally,
the device was heated (46◦C) above the transition temperature40
of the lipids used, cooled to room temperature and imaged using
A
B
Fig. 2 Sampling of ternary lipid mixtures in DIBs. (A) TIRF microscope
images of DIBs composed of DPhPC, DPPC and Chol at different mo-
lar compositions: (1) 1:1:1, (2) 1:3:1, (3) 5:5:10, (4) 3:3:4, (5) 4:2:4, (6)
4:4:2, (7) 4.75:0.5:4.75, and (8) 1:1:8. (1), (3), (4), (5) and (6) lie in the
two-phase region. (2) Lies in the three-phase region. (7) and (8) lie in
the single-phase region. Scale bar 5 µm. Phase boundary is reproduced
from Veatch et al. 12 (B) TIRF microscope images of DIBs composed of
DPhPC, bSM and Chol at different molar compositions: (1) 2:2:1, (2)
5:5:0, (3) 1:1:1, (4) 3.75:3.75:2.5, (5) 10:5:5, (6) 9:9:2, (7) 6.25:0.65:3,
and (8) 3:2.8:4.). (1), (3), (4), (5), (6) and lie in the Lo/Ld phase coex-
istence region. (2) lies in the So/Ld phase coexistence region. (7) lies
in the Ld single-phase region. Phase boundaries are reproduced from
Bezlyepkina et al. 8
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TIRF microscopy.
Lipid titration. Solutions of lipids in oil were prepared; the
final concentration of lipids in each vial was chosen to maintain
the total net concentration of lipids in the device constant. Like-
wise, the accumulated volume of the individual titrations (6005
µL) was chosen so not to exceed the volume of a single microflu-
idic well (2.5 mL). To achieve a change in bilayer composition,
the content of a prepared vial was pipetted into the oil solution
contained within the microfluidic device. Immediately following
titration the device was heated above the transition temperature10
of all components (46◦C) for 15 minutes and then imaged using
TIRF microscopy.
Domain tracking. A custom Matlab (Math Works) script was
written to identify domains and measure their size and diffusion
parameters. Briefly, a 50% intensity threshold was applied to15
identify domains. Segmented areas are then isolated based on
their size (area > 0.25 µm2) and circularity (i.e. ratio of the ma-
jor axis length to minor axis length) (rmin/rmax > 0.8). Domains
were then tracked by determining their centroid position. Dif-
fusion coefficients were calculated from a weighted least-square20
fit of the gradient from a plot of the mean square displacements
(MSD) versus time. Assuming circular shape, the radius of a do-
main was then calculated from its area.
MSDs were subsequently analysed as a function of domain
radius, r. After comparison of a number of theoretical mod-25
els9,37–40, these data were best fit by the Guigas-Weiss model: an
empirically-derived fit to the diffusion of different-sized domains
in free-standing membranes obtained from molecular dynamics
simulations41. The fit is mathematically described as:
D=
kBT arctan(c/r)
8ηwr
(1)
Where c is a membrane viscosity-dependant scaling factor, and30
ηw the bulk viscosity of water.
Results
DIBs containing phase-separating lipid mixtures were prepared
following our previously published method36.
A wide-field confocal image of a representative DIB with35
liquid-ordered (Lo) liquid-disordered (Ld) phase coexistence is
shown in Fig.1B. A mixture of 1:1:1 mol% 1,2-diphytanoyl-sn-
glycero-3-phosphocholine (DPhPC), 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC), and cholesterol (Chol) was used. 1
mol% TRITC-DHPE labelled the Ld phase. Phase-separated DIBs40
showed essentially consistent domain size and morphology, how-
ever near the bilayer edge, where there is contact between bilayer
and the two adjoining monolayers on the droplet and agarose
substrate, a gradual variation in domain morphology and area
fraction was observed.45
Focusing on the central region, specific ternary lipid mixtures
were sampled to test if compositions where phase-separation has
been previously reported for GUVs were also consistent with those
we observe in DIBs. Figure 2 shows phase diagrams and Total
Internal Reflection Fluorescence (TIRF) micrographs of DIBs con-50
taining different ternary lipid mixtures of either: DPhPC, DPPC,
and Chol; or DPhPC, brain-sphingomyelin (bSM) and Chol. 1
A
B
Fig. 3 (A) Inset shows an image sequence following heating of a DIB
formed from a 1:1:1 DPhPC:bSM:Chol mixture with 1% TRITC-DHPE
used as marker for the Ld phase. Heating from 22 (top) to 31◦C (bot-
tom) over a period of 5 minutes results in a decrease in Lo area fraction.
Scale bar 10 µm. (B) Inset shows a 6 s time series of images that show
diffusing microdomains. A plot of diffusion coefficient vs. domain ra-
dius was fit to the Guigas-Weiss model of domain diffusion (χ2 = 1.329,
ηc = 0.00363 N s m2, c = 6.475× 10−6). Error bars report the standard
deviation (N = 36). Scale bar 10 µm.
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mol% TRITC-DHPE and DiI-C18 were used as markers for the Ld
phase as indicated42. 16 different molar compositions of each
mixture were sampled, and single- and two-phase coexistence
were observed for compositions where such coexistence was ex-
pected.8,12.5
The temperature-dependent depletion of Lo domains in a DIB
(1:1:1 DPhPC:bSM:Chol, 1 mol% TRITC-DHPE) (Fig.3A) was
also exxamined. Domains disappeared as the temperature was
increased from 22 to 31◦C, consistent with the phase transition
temperature of this lipid mixture.10
The diffusion of microscopic Lo lipid domains in phase sep-
arated DIBs were tracked (Fig. 3B). DIBs containing 1:1:1
DPhPC:DPPC:Chol (plus 1 mol% TRITC-DHPE) were formed. Im-
age sequences were analyzed using a custom Matlab script to
identify and track domain motion. We found the size-dependent15
diffusion coefficients for tracked domains were well described
by the Guigas-Weiss41 model for domain motion (χ2 = 1.329),
with membrane viscosity ηm = 1.6 to 5.6× 10−9 N s m−1, and
solvent viscosity ηc = 0.004 N s m−2, matching literature reports
(ηm = 2.4× 10−9 N s m −1 and ηc = 0.001 to 0.05 N s m−2)9,40.20
This suggests that, similar to our previous measurements on lipid
diffusion in single-phase DIBs35, the presence of the underlying
hydrogel film does not have any major effects on domain diffu-
sion.
Given the similar phase diagrams, transition temperatures, and25
domain diffusion to those previously reported, we conclude that
lipid domains formed in DIBs are essentially similar to those
formed in other artificial bilayers, including GUVs.
We then sought to modulate the lipid composition in individual
bilayers. Firstly DIBs composed of 1:1 DPhPC:bSM, were formed30
and visualized using TIRF microscopy. Here, 1 mol% of DiI-C18
was used for visualization of the Ld phase. By titrating solutions
of DPhPC:bSM:Chol into the oil phase surrounding the DIB in
a series of sequential steps (Fig.4A) the composition was varied.
This titration was designed to cross phase boundaries and provide35
visual confirmation of a compositional change in the bilayer. The
titer was calculated so that the total concentration of the lipids
in the oil phase was kept constant at 8.7 mg mL−1. For the lipid
compositions used in this work, DIBs are most efficiently formed,
and are optimally stable, at a concentration of 8.7 mg mL−1, Be-40
low this optimum, droplet stability decreases, above this concen-
tration, the time required for monolayer assembly increases36.
Working at the specified concentration ensures a good compro-
mise between stability and equilibration time. The droplets were
heated to 46◦C and then cooled to room temperature to ensure45
good mixing of bilayer components before imaging. A second,
reversible, titration was also performed (Fig.4B), here a DIB at
an initial composition of 1:1:1.6 DPhPC:bSM:Chol (again, plus
1 mol% of DiI-C18), was modulated to cross between the two-
to single- component regions of the phase diagram by the addi-50
tion of lipid solutions to the oil phase. We show a total of three
transitions across the phase boundary within the same bilayer by
sequential addition of solutions of 0:0:1.4, 0.875:0.875:0, and
0:0:2.625 DPhPC:bSM:Chol.
A
B
Fig. 4 Control of bilayer composition. (A) Titration of cholesterol into a
DPhPC:bSM bilayer. (a) lies within the So-Ld phase coexistence region.
(b) and (c) lie in the two-phase Lo-Ld coexistance region. (d) lies in the
single-phase Ld region. Initial molar ratio of lipids at (a) is 1:1:0. Final
molar ratio at (d) is 1:1:8. (B) Reversible titration of lipids reveals domain
switching. Three titrations are performed: (1) to (3), (3) to (2) and (2)
to (3). Initial lipid molar concentration, (1), is 1:1:1.6. Final lipid molar
concentration, (3), is 1:1:3. Scale bars 17 µm.
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Limitations
We note three potential limitations: (1) Our protocol exploited
heating of the droplets following each titration; this step can be
eliminated, but only at the expense of longer equilibration times;
(2) The timescale of composition switching reported here (min-5
utes) is long compared to the timescale of many biological pro-
cesses; (3) The number of compositional changes must be even-
tually limited by lipid solubility, although in this work we are well
below these limits.
Conclusions10
These results show controlled and reversible compositional
changes within an individual bilayer. Both the compositions asso-
ciated with single- and two-phase regions of the phase diagram,
and the associated changes in domain area fraction (e.g. 32.4% at
(a), 12.6% at (b), 32.8% at (c) and 0% at (d) in Fig.4A) are con-15
sistent with the phase behavior expected for similar three compo-
nent lipid mixtures9,13. DIB compositions achieved by titration
are equivalent to those formed by specific sampling. This can
be visually confirmed by comparing points a, b, and c in Fig.4A
with points 2, 1 and 8 in Fig.4B. Within the limits imposed by20
preparation of specific compositions, and the time required for
a composition to equilibrate, the phase behaviour observed for
a specific lipid composition is reproducible. State 3 of Fig.4B
is close to the phase boundary. It is anticipated that the minor
differences observed in the images of state 3 are due to system-25
atic errors in the titration of small volumes and the time taken
between equilibration and observation. These minor differences
are not observed, for example, in Fig.4A were the points chosen
lie far from the phase boundary and are, thus, less prone to be
affected by technical uncertainties. We believe this is a general30
method of on-demand control of DIB composition. This gener-
ality is in contrast to previous reported methods: For example,
glycolipid content has been modulated in SLBs43, however our
method is not limited to changes resulting from the action of gly-
colipid transfer protein; Charged lipids have also been used to35
achieve vesicle fusion with SLBs26, however this also places sig-
nificant restrictions on lipid composition.
This work presents a methodology to systematically modulate
the lipid composition of an individual bilayer. Given that DIBs
can be used to generate asymmetric bilayers44, and that a wide40
variety of complex membrane proteins can be readily incorpo-
rated45, this work provides a route to explore the precise lipid
dependence of individual membrane proteins in situ. Using DIBs
we have shown it is possible to form phase-separated lipid bilay-
ers with precise and homogenous compositions, and to tune the45
composition of an individual bilayer through direct titration of bi-
layer components. This tool will be useful in creating more com-
plex mimics of the cell membrane to study phenomena including
critical demixing, and protein driven phase separation10,46.
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